
1. infect immun. 2011 mar;79(3):1143-52. doi: 10.1128/iai.01034-10. epub 2010 dec
28.

strain-transcending fc-dependent killing plasmodium falciparum merozoite
surface protein 2 allele-specific human antibodies.

stubbs j(1), olugbile s, saidou b, simpore j, corradin g, lanzavecchia a.

author information: 
(1)institute research biomedicine, bellinzona, switzerland.
janine@burnet.edu.au

it widely accepted antibody responses human parasitic
pathogen plasmodium falciparum protect host rigors severe malaria
and death. however, continuing need development vitro
correlate assays immune protection. end, capacity human
monoclonal polyclonal antibodies eliciting phagocytosis parasite
growth inhibition via fcγ receptor-dependent mechanisms explored. in
examining extent sequence diversity merozoite surface protein 2
(msp2) results evasion antibody responses, unexpectedly high level
of heterologous function measured allele-specific human antibodies. the
dependence fcγ receptors opsonic phagocytosis monocyte-mediated
antibody-dependent parasite inhibition demonstrated mutation fc
domain monoclonal antibodies msp2 novel vaccine candidate, 
peptide 27 gene pff0165c. described flow cytometry-based functional 
assays expected useful assessing immunity naturally infected and
vaccinated individuals prioritizing among blood-stage antigens for
inclusion blood-stage vaccines.

doi: 10.1128/iai.01034-10 
pmcid: pmc3067485
pmid: 21189324  [indexed medline]

